Artificial Intelligence

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

A new report reveals a chasm between executive AI ambition and employee readiness, putting billions in tech investments at risk. Here's why HR is key.

New analytics in the duPont REGISTRY Garage app bring Wall Street-style charts to car collecting, empowering owners to trade passion assets like stocks.

An Atlanta clinic combines lasers, biologics, and AI to challenge traditional joint surgery. Can a new marketing push make it a national alternative?

Texada Software's new AI tool promises to find millions in hidden damage for equipment rental firms, but can it overcome industry skepticism and hurdles?

ECGI Holdings is testing a platform to turn mortgages into digital tokens, a move that could disrupt the $2.2 trillion US mortgage industry. Here's how.

New platform enhancements use 'English-as-Code' to help enterprises move AI from risky pilots to reliable, auditable production systems.

A new insurer contract expands Rocket Doctor's telehealth network to millions of New Yorkers on Medicaid and Medicare, aiming to close critical care gaps.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

A new deal brings Nanox's low-radiation, cost-effective Nanox.ARC to orthopedic clinics, aiming to reshape point-of-care diagnostics in the region.

A new agreement could see South Korea's INNOSPACE launch from Canada, positioning Spaceport Nova Scotia as a key player in the global space race.

A new partnership between Dstillery, Keynes, and The Trade Desk cuts a 48-hour workflow to 5 minutes, heralding a new era of autonomous AI in advertising.

A landmark study of 7,600 law firm websites reveals most are neurologically misaligned with people in crisis. The solution? 'Digital trauma rooms.'

Amid a strategic overhaul, Hepion Pharmaceuticals is licensing a novel RNA-based liquid biopsy, aiming to transform early liver cancer detection.

A new partnership links verified proctoring with digital badges, aiming to end credential fraud and restore trust in online learning and certifications.

A novel drug delivery system could revolutionize Alzheimer's treatment, and Acumen Pharmaceuticals is leading the charge with its targeted therapy.

A new report reveals 87% of firms use AI in customer education, but a dangerous lack of strategy and governance threatens quality, security, and ROI.

A new partnership fuses marketing muscle with AI tech to launch a health platform in China, but it faces major regulatory and privacy hurdles.

A new AI reasoning agent promises to move telcos toward Level 4 autonomy, automating complex network operations and boosting efficiency.

Cognitiv's co-founders make ADWEEK's AI Power 50, a nod to their early bet on deep learning that is now reshaping advertising and beyond.